Home/Torqur/Prof. Dr. Michael N. Hall
PD

Prof. Dr. Michael N. Hall

Chairman and Non-Executive Board Member

Torqur

Therapeutic Areas

Torqur Pipeline

DrugIndicationPhase
Bimiralisib (PQR309)Actinic KeratosisPhase 2
Next-gen PI3K/mTOR inhibitorsOncologyPre-clinical